Sciencast Management’s Haemonetics HAE Stock Holding History

Sciencast Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,047	Closed	-$217K	–	629
2021 Q4	$217K	Buy	+4,047	New	+$247K	0.04%	426
2021 Q2	–	Sell	-13,943	Closed	-$1.59M	–	559
2021 Q1	$1.59M	Buy	13,943 +12,191	+696%	+$1.51M	0.32%	98
2020 Q4	$215K	Buy	+1,752	New	+$189K	0.04%	410
2020 Q1	–	Sell	-2,021	Closed	-$230K	–	422
2019 Q4	$230K	Buy	+2,021	New	+$245K	0.06%	414

Other funds holding HAE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Sciencast Management's HAE Position: Q1 2022 in Review

Sciencast Management sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 4,047 shares — an estimated $217K sold.

Sciencast Management first reported a position in HAE in Q4 2019 and held it in 4 quarters. The position peaked at $1.59M in Q1 2021. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

Sciencast Management reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
Sciencast Management sold 4,047 Haemonetics shares in Q1 2022, an estimated $217K.
Sciencast Management first reported a position in Haemonetics in Q4 2019 and held it in 4 quarters.
Sciencast Management's Haemonetics position peaked at $1.59M in Q1 2021.
242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Sciencast Management's 13F filing for Q1 2022, filed 26 Apr 2022.